Cris De Luca
Partner at Sanofi Ventures
Cambridge, Massachusetts
Overview
Work Experience
Partner, Digital and AI Investments at Sanofi Ventures
2020 - Current
Partner at Sanofi Ventures leading venture capital investments in Digital Health, AI & Data Science Innovation, globally. As the corporate venture arm of Sanofi, Sanofi Ventures invests in the innovators behind the miracles of science who are passionate about improving human health. Sanofi Ventures serves as an entry point to the innovation ecosystem for Sanofi, strategically investing in early-stage transformational science and technology, when companies are too early to partner with or acquire. We invest in top-tier biotech and digital health/AI companies that focus on helping patients and transforming the practice of medicine. We invest across all stages of the private company lifecycle, from Seed to Series B and beyond, while leading financings, serving on boards, and taking pride in working alongside portfolio companies to drive long-term value. Learn more at www.sanofiventures.com
Board Member
2022
Empatica is an affective computing company focused on human data analytics.
Raised $33,729,980.00 from RA Capital Management, Sanofi Ventures and Black Opal Ventures.
Board Member
2022
Board Member
2021
Medisafe is a personalized tech platform that helps people manage their medications while providing insight into their daily habits.
Raised $51,500,000.00 from Octopus Ventures, lool ventures, Sanofi Ventures, Triventures, 7wire Ventures, OurCrowd, Leumi Partners, Consensus Business Group, ALIVE Israel HealthTech Fund and Pitango VC.
Board Member
2020
Click Therapeutics delivers safe and effective digital treatments to patients in need.
Raised $957,652,435.00 from HSBC Innovation Banking and Silicon Valley Bank.
Board Observer
2021
Omada Health is a digital behavioral medicine company that helps members change their mindsets to improve health and build lasting change.
Raised $528,520,000.00 from Trousdale Ventures, Wellington Management, Empede Capital, aMoon Fund, Civilization Ventures, Fidelity, Perceptive Advisors and Revelation Partners.
Board Observer
2020
Aetion provides real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.
Raised $203,600,000.00 from B Capital, Warburg Pincus, Foresite Capital, Flare Capital Partners and New Enterprise Associates.
Board Observer
2020 - 2021
Common Sensing develops and manufactures data-driven hardware and software solutions for people using injectable medicine.
Raised $13,883,285.00 from Pleasant Bay Capital Partners.
Investor
2020 - 2021
Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.
Raised $347,500,000.00 from Lux Capital, RTW Investments, Mubadala Capital Ventures, Pura Vida Investments, Casdin Capital, BlackRock, LifeSci Venture Partners, Redmile Group, PPD clinical research business of Thermo Fisher Scientific and Samsara BioCapital.
Venture Partner
2019 - 2020
FundRx is a venture capital platform that builds and invests in the next-generation of digital health and life sciences startups. Built on a community of hundreds of venture partners and fellows – themselves physicians, scientists, and industry executives – contributing their capital, time, and expertise to the FundRx portfolio, providing exceptional hands-on support and guidance to nurture great companies. Leading with a scientific approach to investing, working with a distributed network of experts to peer-review prospective startups, and pioneers in venture capital technology – with a dedicated engineering organization enabling advanced analytics and screening of investments. Headquartered in New York City, with offices in Chicago and San Francisco
Venture Fellow
2018 - 2019
The next-generation of healthcare and life science venture capital.